IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95% Market Closed
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IRLAB Therapeutics AB
Interest Income Expense Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Interest Income Expense
kr2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Interest Income Expense
-kr115.2m
CAGR 3-Years
-23%
CAGR 5-Years
-133%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Interest Income Expense
kr56m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Interest Income Expense
-kr97.3m
CAGR 3-Years
-177%
CAGR 5-Years
-219%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Interest Income Expense
kr2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Interest Income Expense
kr42.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Interest Income Expense?
Interest Income Expense
2.9m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Interest Income Expense amounts to 2.9m SEK.

Back to Top